# Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

> **NCT01473732** · NA · TERMINATED · sponsor: **Montefiore Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Chronic Allograft Injury
- Calcineurin Inhibitor Toxicity

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolic acid

## Key facts

- **NCT ID:** NCT01473732
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** terminated after 2 patients due to difficulty in enrollment
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473732, "Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01473732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*